|
88
|
306
|
5jgdA |
Crystal structure of human tak1/tab1 fusion protein in complex with ligand 12 |
|
81
|
306
|
5j7bA |
The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-n-(5-fluoro-1h-indazol-3-yl)quinolin-4-amine (gsk583), a highly potent and selective inhibitor of rip2 kinase, gsk583 complex |
|
90
|
287
|
5khwA |
Crystal structure of jak1 in complex with adp |
|
78
|
275
|
5k9iA |
Crystal structure of c-src in complex with a covalent lysine probe |
|
79
|
303
|
5j5tA |
Glk co-crystal structure with aminopyrrolopyrimidine inhibitor |
|
93
|
309
|
5j7hA |
Crystal structure of anaplastic lymphoma kinase (alk) bound by brigatinib |
|
78
|
276
|
5j5sA |
Src kinase in complex with a sulfonamide inhibitor |
|
83
|
309
|
5j79A |
The identification and pharmacological characterization of 6-(tert-butylsulfonyl)-n-(5-fluoro-1h-indazol-3-yl)quinolin-4-amine (gsk583), a highly potent and selective inhibitor of rip2 kinase, compound 3 complex |
|
100
|
338
|
5izfA |
Complex of pka with the bisubstrate protein kinase inhibitor arc-1408 |
|
99
|
312
|
5iuhA |
Crystal structure of the anaplastic lymphoma kinase (alk) in complex with 5d |
|
97
|
292
|
5ih6A |
Human casein kinase 1 isoform delta (kinase domain) in complex with epiblastin a derivative |
|
78
|
273
|
5ipjA |
Crystal structure of human pim-1 kinase in complex with a quinazolinone-pyrrolopyrrolone inhibitor. |
|
85
|
317
|
5iu2A |
Discovery of imidazoquinolines as a novel class of potent, selective and in vivo efficacious cot kinase inhibitors |
|
78
|
271
|
5itaA |
Crystal structure of braf kinase domain bound to az-vem |
|
101
|
312
|
5iugA |
Crystal structure of anaplastic lymphoma kinase (alk) in complex with 5a |
|
91
|
300
|
5ig1A |
Crystal structure of s. rosetta camkii kinase domain |
|
93
|
293
|
5ih5A |
Human casein kinase 1 isoform delta (kinase domain) in complex with epiblastin a |
|
79
|
298
|
5ievA |
Crystal structure of bay 1000394 (roniciclib) bound to cdk2 |
|
82
|
296
|
5imeA |
Crystal structure of p21-activated kinase 1 (pak1) in complex with compound 9 |
|
96
|
293
|
5ih4A |
Human casein kinase 1 isoform delta apo (kinase domain) |
|
81
|
274
|
5iisA |
Design, synthesis and structure activity relationship of potent pan-pim kinase inhibitors derived from the pyridyl-amide scaffold |
|
84
|
298
|
5if1A |
Crystal structure apo cdk2/cyclin a |
|
84
|
292
|
5imxA |
Anaplastic lymphoma kinase (alk) catalytic domain complexed with novel inhibitor 3-sulfonylpyrazol-4-amino pyrimidine |
|
82
|
298
|
5ieyA |
Crystal structure of a cdk inhibitor bound to cdk2 |
|
81
|
284
|
5ia1A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with mln8054 |
|
82
|
286
|
5ia0A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with alisertib (mln8237) |
|
85
|
298
|
5iexA |
Crystal structure of (r,s)-s-{4-[(5-bromo-4-{[(2r,3r)-2-hydroxy-1-methylpropyl]oxy}- pyrimidin-2-yl)amino]phenyl}-s-cyclopropylsulfoximide bound to cdk2 |
|
102
|
363
|
5idnA |
Cdk8-cycc in complex with [(s)-2-(4-chloro-phenyl)-pyrrolidin-1-yl]-(3-methyl-1h-pyrazolo[3,4-b]pyridin-5-yl)-methanone |
|
87
|
292
|
5i9vA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with ags |
|
91
|
291
|
5ia2A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with compound 66 |
|
99
|
360
|
5idpA |
Cdk8-cycc in complex with (3-amino-1h-indazol-5-yl)-[(s)-2-(4-fluoro-phenyl)-piperidin-1-yl]-methanone |
|
82
|
293
|
5i9zA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with danusertib (pha739358) |
|
83
|
291
|
5i9wA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with anp |
|
104
|
362
|
5icpA |
Cdk8-cycc in complex with [(s)-2-(4-chloro-phenyl)-pyrrolidin-1-yl]-(5-methyl-imidazo[5,1-b][1,3,4]thiadiazol-2-yl)-methanone |
|
104
|
365
|
5i5zA |
Cdk8-cycc in complex with 8-(1-methyl-2,2-dioxo-2,3-dihydro-1h-2l6-benzo[c]isothiazol-5-yl)-[1,6]naphthyridine-2-carboxylic acid methylamide |
|
80
|
295
|
5ia3A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with pd173955 |
|
83
|
273
|
5ia4A |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with foretinib (xl880) |
|
91
|
293
|
5i9xA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with bosutinib (ski-606) |
|
90
|
297
|
5i9yA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with dasatinib |
|
79
|
289
|
5i0bA |
Structure of pak4 |
|
87
|
284
|
5i4nA |
Crystal structure of the e596a v617f mutant jak2 pseudokinase domain bound to mg-atp |
|
93
|
304
|
5hznA |
Structure of nvp-aew541 in complex with igf-1r kinase |
|
86
|
302
|
5i3rA |
Crystal structure of bmp-2-inducible kinase in complex with an indazole inhibitor |
|
78
|
292
|
5hq0A |
Ternary complex of human proteins cdk1, cyclin b and cks2, bound to an inhibitor |
|
89
|
300
|
5hx8A |
Jak1 complex with 4-[(4-aminocyclohexyl)amino]-3-(1h-benzimidazol-2-yl)-1h-pyridin-2-one |
|
72
|
311
|
5hvkA |
Crystal structure of limk1 mutant d460n in complex with full-length cofilin-1 |
|
75
|
285
|
5hx6A |
Crystal structure of rip1 kinase with a benzo[b][1,4]oxazepin-4-one |
|
80
|
293
|
5horA |
Crystal structure of c-met-m1250t in complex with sar125844. |
|
115
|
328
|
5htbA |
Crystal structure of haspin (gsg2) in complex with bisubstrate inhibitor arc-3353 |
|
81
|
289
|
5ho7A |
Discovery of novel 7-azaindoles as pdk1 inhibitors |
